The Combination of Betahistine and Oxybutynin Increases Respiratory Control Sensitivity (Loop Gain) in People with Obstructive Sleep Apnea: A Randomized, Placebo-Controlled Trial

References

• Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med. 1993;328:1230–1235. doi:10.1056/NEJM199304293281704
   PubMed Web of Science ®Google Scholar
• Eckert DJ, White DP, Jordan AS, Malhotra A, Wellman A. Defining phenotypic causes of obstructive sleep apnea. Identification of novel therapeutic targets. Am J Respir Crit Care Med. 2013;188:996–1004. doi:10.1164/rccm.201303-0448OC
   PubMed Web of Science ®Google Scholar
• Pepin JL, Eastwood P, Eckert DJ. Novel avenues to approach non-CPAP therapy and implement comprehensive OSA care. Eur Respir J. 2021;2101788. doi:10.1183/13993003.01788-2021
   Web of Science ®Google Scholar
• Taranto-Montemurro L, Messineo L, Sands SA, et al. The combination of atomoxetine and oxybutynin greatly reduces obstructive sleep apnea severity. A randomized, placebo-controlled, double-blind crossover trial. Am J Respir Crit Care Med. 2019;199:1267–1276. doi:10.1164/rccm.201808-1493OC
   PubMed Web of Science ®Google Scholar
• Messineo L, Carter SG, Taranto-Montemurro L, et al. Addition of zolpidem to combination therapy with atomoxetine-oxybutynin increases sleep efficiency and the respiratory arousal threshold in obstructive sleep apnoea: a randomized trial. Respirology. 2021;26:878–886. doi:10.1111/resp.14110
   PubMed Web of Science ®Google Scholar
• Lim R, Messineo L, Grunstein RR, Carberry JC, Eckert DJ. The noradrenergic agent reboxetine plus the antimuscarinic hyoscine butylbromide reduces sleep apnoea severity: a double-blind, placebo-controlled, randomised crossover trial. J Physiol. 2021;599:4183–4195. doi:10.1113/JP281912
   PubMed Web of Science ®Google Scholar
• Taranto-Montemurro T-M, Messineo M, Wellman W. Targeting endotypic traits with medications for the pharmacological treatment of obstructive sleep apnea. a review of the current literature. J Clin Med. 2019;8:1846. doi:10.3390/jcm8111846
   PubMed Web of Science ®Google Scholar
• Messineo L, Eckert DJ, Lim R, et al. Zolpidem increases sleep efficiency and the respiratory arousal threshold without changing sleep apnoea severity and pharyngeal muscle activity. J Physiol. 2020;598:4681–4692. doi:10.1113/JP280173
   PubMed Web of Science ®Google Scholar
• Dempsey JA, Veasey SC, Morgan BJ, O’Donnell CP. Pathophysiology of sleep apnea. Physiol Rev. 2010;90:47–112. doi:10.1152/physrev.00043.2008
   PubMed Web of Science ®Google Scholar
• Grace KP, Hughes SW, Horner RL. Identification of the mechanism mediating genioglossus muscle suppression in REM sleep. Am J Respir Crit Care Med. 2013;187:311–319.
   PubMed Web of Science ®Google Scholar
• Chan E, Steenland HW, Liu H, Horner RL. Endogenous excitatory drive modulating respiratory muscle activity across sleep-wake states. Am J Respir Crit Care Med. 2006;174:1264–1273. doi:10.1164/rccm.200605-597OC
   PubMed Web of Science ®Google Scholar
• Kivipelto L, Majane EA, Yang HY, Panula P. Immunohistochemical distribution and partial characterization of FLFQPQRFamidelike peptides in the central nervous system of rats. J Comp Neurol. 1989;286:269–287. doi:10.1002/cne.902860211
   PubMed Web of Science ®Google Scholar
• Traiffort E, Leurs R, Arrang JM, et al. Guinea pig histamine H1 receptor. I. Gene cloning, characterization, and tissue expression revealed by in situ hybridization. J Neurochem. 1994;62:507–518. doi:10.1046/j.1471-4159.1994.62020507.x
   PubMed Web of Science ®Google Scholar
• Bouthenet ML, Ruat M, Sales N, Garbarg M, Schwartz JC. A detailed mapping of histamine H1-receptors in Guinea-pig central nervous system established by autoradiography with [125I]iodobolpyramine. Neuroscience. 1988;26:553–600. doi:10.1016/0306-4522(88)90167-4
   PubMed Web of Science ®Google Scholar
• Traiffort E, Pollard H, Moreau J, et al. Pharmacological characterization and autoradiographic localization of histamine H2 receptors in human brain identified with [125I]iodoaminopotentidine. J Neurochem. 1992;59:290–299. doi:10.1111/j.1471-4159.1992.tb08903.x
   PubMed Web of Science ®Google Scholar
• Xie L, Wu Q, Hu W, et al. Impact of histaminergic H3 receptor antagonist on hypoglossal nucleus in chronic intermittent hypoxia conditions. Psychopharmacology. 2021;238:121–131. doi:10.1007/s00213-020-05663-0
   PubMed Web of Science ®Google Scholar
• Bastedo T, Chan E, Park E, Liu H, Horner RL. Modulation of genioglossus muscle activity across sleep-wake states by histamine at the hypoglossal motor pool. Sleep. 2009;32:1313–1324. doi:10.1093/sleep/32.10.1313
   PubMed Web of Science ®Google Scholar
• Liu ZL, Wu X, Luo YJ, et al. Signaling mechanism underlying the histamine-modulated action of hypoglossal motoneurons. J Neurochem. 2016;137:277–286. doi:10.1111/jnc.13548
   PubMed Web of Science ®Google Scholar
• Neuzeret PC, Sakai K, Gormand F, et al. Application of histamine or serotonin to the hypoglossal nucleus increases genioglossus muscle activity across the wake-sleep cycle. J Sleep Res. 2009;18:113–121. doi:10.1111/j.1365-2869.2008.00708.x
   PubMed Web of Science ®Google Scholar
• Vanni-Mercier G, Gigout S, Debilly G, Lin JS. Waking selective neurons in the posterior hypothalamus and their response to histamine H3-receptor ligands: an electrophysiological study in freely moving cats. Behav Brain Res. 2003;144:227–241. doi:10.1016/S0166-4328(0300091-3
   PubMed Web of Science ®Google Scholar
• Haas HL, Sergeeva OA, Selbach O. Histamine in the nervous system. Physiol Rev. 2008;88:1183–1241.
   PubMed Web of Science ®Google Scholar
• Taranto-Montemurro L, Sands SA, Edwards BA, et al. Desipramine improves upper airway collapsibility and reduces OSA severity in patients with minimal muscle compensation. Eur Respir J. 2016;48:1340–1350. doi:10.1183/13993003.00823-2016
   PubMed Web of Science ®Google Scholar
• Taranto-Montemurro L, Edwards BA, Sands SA, et al. Desipramine increases genioglossus activity and reduces upper airway collapsibility during non-REM sleep in healthy subjects. Am J Respir Crit Care Med. 2016;194:878–885. doi:10.1164/rccm.201511-2172OC
   PubMed Web of Science ®Google Scholar
• Kang JA, Lee K, Lee KM, et al. Desipramine inhibits histamine H1 receptor-induced Ca2+ signaling in rat hypothalamic cells. PLoS One. 2012;7:e36185. doi:10.1371/journal.pone.0036185
   PubMed Web of Science ®Google Scholar
• Dauvilliers Y, Verbraecken J, Partinen M, et al. Pitolisant for daytime sleepiness in patients with obstructive sleep apnea who refuse continuous positive airway pressure treatment. a randomized trial. Am J Respir Crit Care Med. 2020;201:1135–1145. doi:10.1164/rccm.201907-1284OC
   PubMed Web of Science ®Google Scholar
• Pepin JL, Georgiev O, Tiholov R, et al. Pitolisant for residual excessive daytime sleepiness in OSA patients adhering to CPAP: a randomized trial. Chest. 2021;159:1598–1609. doi:10.1016/j.chest.2020.09.281
   PubMed Web of Science ®Google Scholar
• Lacour M, Sterkers O. Histamine and betahistine in the treatment of vertigo: elucidation of mechanisms of action. CNS Drugs. 2001;15:853–870. doi:10.2165/00023210-200115110-00004
   PubMed Web of Science ®Google Scholar
• Arrang JM, Garbarg M, Quach TT. Actions of betahistine at histamine receptors in the brain. Eur J Pharmacol. 1985;111:73–84. doi:10.1016/0014-2999(85)90115-3
   PubMed Web of Science ®Google Scholar
• Schlicker E, Fink K, Hinterthaner M, Gothert M. Inhibition of noradrenaline release in the rat brain cortex via presynaptic H3 receptors. Naunyn Schmiedebergs Arch Pharmacol. 1989;340:633–638. doi:10.1007/BF00717738
   PubMed Web of Science ®Google Scholar
• Clapham J, Kilpatrick GJ. Histamine H3 receptors modulate the release of [3H]-acetylcholine from slices of rat entorhinal cortex: evidence for the possible existence of H3 receptor subtypes. Br J Pharmacol. 1992;107:919–923. doi:10.1111/j.1476-5381.1992.tb13386.x
   PubMed Web of Science ®Google Scholar
• Perger E, Taranto Montemurro L, Rosa D, et al. Reboxetine plus oxybutynin for OSA treatment: a 1-week, randomized, placebo-controlled, double-blind crossover trial. Chest. 2021;161:237–247. doi:10.1016/j.chest.2021.08.080
   PubMed Web of Science ®Google Scholar
• Taranto-Montemurro L, Messineo L, Azarbarzin A, et al. Effects of the combination of atomoxetine and oxybutynin on OSA endotypic traits. Chest. 2020;157:1626–1636. doi:10.1016/j.chest.2020.01.012
   PubMed Web of Science ®Google Scholar
• Lim R, Carberry JC, Wellman A, Grunstein R, Eckert DJ. Reboxetine and hyoscine butylbromide improve upper airway function during nonrapid eye movement and suppress rapid eye movement sleep in healthy individuals. Sleep. 2019;42:zsy261. doi:10.1093/sleep/zsy261
   PubMed Web of Science ®Google Scholar
• The Report of an American Academy of Sleep Medicine Task Force. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. Sleep. 1999;22:667–689. doi:10.1093/sleep/22.5.667
   PubMed Web of Science ®Google Scholar
• Vakulin A, Baulk SD, Catcheside PG, et al. Effects of alcohol and sleep restriction on simulated driving performance in untreated patients with obstructive sleep apnea. Ann Intern Med. 2009;151:447–455. doi:10.7326/0003-4819-151-7-200910060-00005
   PubMed Web of Science ®Google Scholar
• Berry RB, Brooks R, Gamaldo C, et al. AASM scoring manual updates for 2017 (Version 2.4). J Clin Sleep Med. 2017;13:665–666. doi:10.5664/jcsm.6576
   PubMed Web of Science ®Google Scholar
• Sands SA, Edwards BA, Terrill PI, et al. Phenotyping pharyngeal pathophysiology using polysomnography in patients with obstructive sleep apnea. Am J Respir Crit Care Med. 2018;197:1187–1197. doi:10.1164/rccm.201707-1435OC
   PubMed Web of Science ®Google Scholar
• Terrill PI, Edwards BA, Nemati S, et al. Quantifying the ventilatory control contribution to sleep apnoea using polysomnography. Eur Respir J. 2015;45:408–418. doi:10.1183/09031936.00062914
   PubMed Web of Science ®Google Scholar
• Sands SA, Terrill PI, Edwards BA, et al. Quantifying the arousal threshold using polysomnography in obstructive sleep apnea. Sleep. 2018;41:zsx183.
   PubMed Web of Science ®Google Scholar
• Feldman JL, Mitchell GS, Nattie EE. Breathing: rhythmicity, plasticity, chemosensitivity. Annu Rev Neurosci. 2003;26:239–266. doi:10.1146/annurev.neuro.26.041002.131103
   PubMed Web of Science ®Google Scholar
• Messineo L, Taranto-Montemurro L, Azarbarzin A, et al. Breath-holding as a means to estimate the loop gain contribution to obstructive sleep apnoea. J Physiol. 2018;596:4043–4056. doi:10.1113/JP276206
   PubMed Web of Science ®Google Scholar
• Dutschmann M, Bischoff AM, Busselberg D, Richter DW. Histaminergic modulation of the intact respiratory network of adult mice. Pflugers Arch. 2003;445:570–576. doi:10.1007/s00424-002-0904-z
   PubMed Web of Science ®Google Scholar
• Lazarov N, Rozloznik M, Reindl S, Rey-Ares V, Dutschmann M, Gratzl M. Expression of histamine receptors and effect of histamine in the rat carotid body chemoafferent pathway. Eur J Neurosci. 2006;24:3431–3444. doi:10.1111/j.1460-9568.2006.05241.x
   PubMed Web of Science ®Google Scholar
• Haxhiu MA, Cherniack NS, Altose MD, Kelsen SG. Effect of histamine on respiratory chemosensitivity in conscious goats. Respiration. 1983;44:411–418. doi:10.1159/000194578
   PubMed Web of Science ®Google Scholar
• Del Rio R, Moya EA, Koenig CS, Fujiwara K, Alcayaga J, Iturriaga R. Modulatory effects of histamine on cat carotid body chemoreception. Respir Physiol Neurobiol. 2008;164:401–410. doi:10.1016/j.resp.2008.09.005
   PubMed Web of Science ®Google Scholar
• Moorthy G, Sallee F, Gabbita P, Zemlan F, Sallans L, Desai PB. Safety, tolerability and pharmacokinetics of 2-pyridylacetic acid, a major metabolite of betahistine, in a Phase 1 dose escalation study in subjects with ADHD. Biopharm Drug Dispos. 2015;36:429–439. doi:10.1002/bdd.1955
   PubMed Web of Science ®Google Scholar
• Nemati S, Edwards BA, Sands SA, et al. Model-based characterization of ventilatory stability using spontaneous breathing. J Appl Physiol. 2011;111:55–67. doi:10.1152/japplphysiol.01358.2010
   PubMed Web of Science ®Google Scholar
• Edwards BA, Sands SA, Skuza EM, et al. Increased peripheral chemosensitivity via dopaminergic manipulation promotes respiratory instability in lambs. Respir Physiol Neurobiol. 2008;164:419–428. doi:10.1016/j.resp.2008.09.003
   PubMed Web of Science ®Google Scholar
• Delpierre S, Fornaris M, Guillot C, Grimaud C. Increased ventilatory chemosensitivity induced by domperidone, a dopamine antagonist, in healthy humans. Bull Eur Physiopathol Respir. 1987;23:31–35.
   PubMedGoogle Scholar
• Schinkel AH, Wagenaar E, Mol CA, van Deemter L. P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs. J Clin Invest. 1996;97:2517–2524. doi:10.1172/JCI118699
   PubMed Web of Science ®Google Scholar
• Sampson MG, Grassino K. Neuromechanical properties in obese patients during carbon dioxide rebreathing. Am J Med. 1983;75:81–90. doi:10.1016/0002-9343(83)91171-3
   PubMed Web of Science ®Google Scholar
• Carroll MS, Patwari PP, Kenny AS, Brogadir CD, Stewart TM, Weese-Mayer DE. Residual chemosensitivity to ventilatory challenges in genotyped congenital central hypoventilation syndrome. J Appl Physiol. 2014;116:439–450. doi:10.1152/japplphysiol.01310.2013
   PubMed Web of Science ®Google Scholar
• Weil JV, McCullough RE, Kline JS, Sodal IE. Diminished ventilatory response to hypoxia and hypercapnia after morphine in normal man. N Engl J Med. 1975;292:1103–1106. doi:10.1056/NEJM197505222922106
   PubMed Web of Science ®Google Scholar
• Robinson RW, Zwillich CW, Bixler EO, Cadieux RJ, Kales A, White DP. Effects of oral narcotics on sleep-disordered breathing in healthy adults. Chest. 1987;91:197–203. doi:10.1378/chest.91.2.197
   PubMed Web of Science ®Google Scholar
• Altree TJ, Chung F, Chan MTV, Eckert DJ. Vulnerability to postoperative complications in obstructive sleep apnea: importance of phenotypes. Anesth Analg. 2021;132:1328–1337. doi:10.1213/ANE.0000000000005390
   PubMed Web of Science ®Google Scholar
• Martins RT, Carberry JC, Wang D, Rowsell L, Grunstein RR, Eckert DJ. Morphine alters respiratory control but not other key obstructive sleep apnoea phenotypes: a randomised trial. Eur Respir J. 2020;55:45.
   Web of Science ®Google Scholar
• Lacour M, Chabbert C. Betahistine treatment in managing vertigo and improving vestibular compensation: clarification. J Vestib Res. 2013;23:139–151. doi:10.3233/VES-130496
   PubMed Web of Science ®Google Scholar
• Schulz KF, Altman DG, Moher D, CONSORT Group. CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomised Trials. PLoS Med. 2010;7(3):e1000251.
   PubMed Web of Science ®Google Scholar